152 related articles for article (PubMed ID: 32748617)
1. Minimally invasive strategies for the treatment of prostate cancer recurrence after radiation therapy: a systematic review.
Mantica G; Chierigo F; Suardi N; Gomez Rivas J; Kasivisvanathan V; Papalia R; Fiori C; Porpiglia F; Terrone C; Esperto F;
Minerva Urol Nefrol; 2020 Oct; 72(5):563-578. PubMed ID: 32748617
[TBL] [Abstract][Full Text] [Related]
2. Nonsurgical Salvage Local Therapies for Radiorecurrent Prostate Cancer: A Systematic Review and Meta-analysis.
Ingrosso G; Becherini C; Lancia A; Caini S; Ost P; Francolini G; Høyer M; Bottero M; Bossi A; Zilli T; Scartoni D; Livi L; Santoni R; Giacomelli I; Detti B
Eur Urol Oncol; 2020 Apr; 3(2):183-197. PubMed ID: 31411996
[TBL] [Abstract][Full Text] [Related]
3. Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation.
Ramsay CR; Adewuyi TE; Gray J; Hislop J; Shirley MD; Jayakody S; MacLennan G; Fraser C; MacLennan S; Brazzelli M; N'Dow J; Pickard R; Robertson C; Rothnie K; Rushton SP; Vale L; Lam TB
Health Technol Assess; 2015 Jul; 19(49):1-490. PubMed ID: 26140518
[TBL] [Abstract][Full Text] [Related]
4. Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes.
Devos B; Al Hajj Obeid W; Andrianne C; Diamand R; Peltier A; Everaerts W; Van Poppel H; Van Velthoven R; Joniau S
World J Urol; 2019 Aug; 37(8):1507-1515. PubMed ID: 30666400
[TBL] [Abstract][Full Text] [Related]
5. Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study.
Clery R; Grande P; Seisen T; Gobert A; Duquesne I; Villers A; Olivier J; Bernhard JC; Robert G; Beauval JB; Prudhomme T; Bruyère F; Lainé-Caroff P; Waltregny D; Guillonneau B; Panarello D; Ruffion A; De Bayser H; de La Taille A; Roupret M
World J Urol; 2019 Aug; 37(8):1491-1498. PubMed ID: 30790014
[TBL] [Abstract][Full Text] [Related]
6. Management of biochemical recurrence after primary treatment of prostate cancer: a systematic review of the literature.
Punnen S; Cooperberg MR; D'Amico AV; Karakiewicz PI; Moul JW; Scher HI; Schlomm T; Freedland SJ
Eur Urol; 2013 Dec; 64(6):905-15. PubMed ID: 23721958
[TBL] [Abstract][Full Text] [Related]
7. High-intensity Focused Ultrasound (HIFU) as salvage therapy for radio-recurrent prostate cancer: predictors of disease response.
Dason S; Wong NC; Allard CB; Hoogenes J; Orovan W; Shayegan B
Int Braz J Urol; 2018; 44(2):248-257. PubMed ID: 29211405
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of the efficacy and safety of high-intensity focussed ultrasound for the primary and salvage treatment of prostate cancer.
Warmuth M; Johansson T; Mad P
Eur Urol; 2010 Dec; 58(6):803-15. PubMed ID: 20864250
[TBL] [Abstract][Full Text] [Related]
9. Salvage Therapy Options for Local Prostate Cancer Recurrence After Primary Radiotherapy: a Literature Review.
Golbari NM; Katz AE
Curr Urol Rep; 2017 Aug; 18(8):63. PubMed ID: 28688020
[TBL] [Abstract][Full Text] [Related]
10. Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients.
Crouzet S; Blana A; Murat FJ; Pasticier G; Brown SCW; Conti GN; Ganzer R; Chapet O; Gelet A; Chaussy CG; Robertson CN; Thuroff S; Ward JF
BJU Int; 2017 Jun; 119(6):896-904. PubMed ID: 28063191
[TBL] [Abstract][Full Text] [Related]
11. Salvage therapy for locally recurrent prostate cancer after radiation.
Marcus DM; Canter DJ; Jani AB; Dobbs RW; Schuster DM; Carthon BC; Rossi PJ
Can J Urol; 2012 Dec; 19(6):6534-41. PubMed ID: 23228288
[TBL] [Abstract][Full Text] [Related]
12. Salvage cryoablation for locally recurrent prostate cancer following primary radiotherapy.
Mouraviev V; Spiess PE; Jones JS
Eur Urol; 2012 Jun; 61(6):1204-11. PubMed ID: 22421081
[TBL] [Abstract][Full Text] [Related]
13. Disease-free survival following salvage cryotherapy for biopsy-proven radio-recurrent prostate cancer.
Williams AK; Martínez CH; Lu C; Ng CK; Pautler SE; Chin JL
Eur Urol; 2011 Sep; 60(3):405-10. PubMed ID: 21185115
[TBL] [Abstract][Full Text] [Related]
14. Salvage cryosurgery for locally recurrent prostate cancer following radiotherapy.
Ahmed S; Lindsey B; Davies J
Prostate Cancer Prostatic Dis; 2005; 8(1):31-5. PubMed ID: 15583704
[TBL] [Abstract][Full Text] [Related]
15. High-intensity focused ultrasound and cryotherapy as salvage treatment in local radio-recurrent prostate cancer.
Autran-Gomez AM; Scarpa RM; Chin J
Urol Int; 2012; 89(4):373-9. PubMed ID: 22797110
[TBL] [Abstract][Full Text] [Related]
16. Prostate specific antigen only progression of prostate cancer.
Moul JW
J Urol; 2000 Jun; 163(6):1632-42. PubMed ID: 10799151
[TBL] [Abstract][Full Text] [Related]
17. Salvage focal and salvage total cryoablation for locally recurrent prostate cancer after primary radiation therapy.
de Castro Abreu AL; Bahn D; Leslie S; Shoji S; Silverman P; Desai MM; Gill IS; Ukimura O
BJU Int; 2013 Aug; 112(3):298-307. PubMed ID: 23826840
[TBL] [Abstract][Full Text] [Related]
18. HIFU as salvage first-line treatment for palpable, TRUS-evidenced, biopsy-proven locally recurrent prostate cancer after radical prostatectomy: a pilot study.
Asimakopoulos AD; Miano R; Virgili G; Vespasiani G; Finazzi Agrò E
Urol Oncol; 2012 Sep; 30(5):577-83. PubMed ID: 21292508
[TBL] [Abstract][Full Text] [Related]
19. Salvage radical prostatectomy after external beam radiation therapy: a systematic review of current approaches.
Matei DV; Ferro M; Jereczek-Fossa BA; Renne G; Crisan N; Bottero D; Mazzarella C; Terracciano D; Autorino R; De Cobelli O
Urol Int; 2015; 94(4):373-82. PubMed ID: 25765848
[TBL] [Abstract][Full Text] [Related]
20. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
